Mechanical occlusion of the left atrial appendage
- PMID: 12950520
- DOI: 10.1046/j.1540-8167.14.s9.11.x
Mechanical occlusion of the left atrial appendage
Abstract
Introduction: Oral anticoagulation therapy reduces significantly the risk of thromboembolism in patients with atrial fibrillation. However, effective oral anticoagulation therapy is not feasible in all patients. The interventional occlusion of the left atrial appendage may reduce the risk of thromboembolism in the latter patients. The aim of this prospective study was to assess the feasibility, safety, and technical aspects of interventionally occluding the left atrial appendage.
Methods and results: The left atrial appendage was interventionally occluded with the new PLAATO device in nine patients. Serial transthoracic and transesophageal echocardiographic studies and neurologic assessment were performed prior to and during the procedure, and <48 hours, 3 months, 6 months, and 1 year after the procedure. Contraindications to oral anticoagulation were bleeding complications in 6 of 9 cases, cerebral aneurysm in 1, and allergies to warfarin therapy in 2 of 9. Baseline echocardiographic studies demonstrated spontaneous echo contrast grade 3 +/- 1, peak emptying velocities of 0.26 +/- 0.12 m/sec, and excluded atrial thrombi in all cases. Interventional occlusion was feasible in all cases. One patient had a minor plexus paresis that resolved within 4 weeks after the procedure. Neurologic assessment during a mean follow-up of 5 +/- 4.4 months did not demonstrate any new neurologic complications. Serial echocardiographic assessment excluded the formation of thrombi on the implanted device and demonstrated its complete thrombosis after 6 months. One patient developed a minimal pericardial effusion 48 hours after the procedure that resolved within 3 months.
Conclusion: Interventional occlusion of the left atrial appendage is feasible and safe in patients with atrial fibrillation and contraindications to oral anticoagulation therapy. Furthermore, no neurologic complications, development of atrial thrombi, or thrombus formation on the device were observed during follow-up. Future prospective studies are needed to clarify the long-term treatment effect of this new technique.
Comment in
-
Percutaneous left atrial appendage transcatheter occlusion: an effective and safe protection against stroke or embolism?J Cardiovasc Electrophysiol. 2004 Mar;15(3):373; author reply 373-4. doi: 10.1046/j.1540-8167.2004.03693.x. J Cardiovasc Electrophysiol. 2004. PMID: 15030433 No abstract available.
Similar articles
-
Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.JACC Cardiovasc Interv. 2009 Jul;2(7):594-600. doi: 10.1016/j.jcin.2009.05.005. JACC Cardiovasc Interv. 2009. PMID: 19628179 Clinical Trial.
-
Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.Rev Port Cardiol. 2013 Jun;32(6):461-71. doi: 10.1016/j.repc.2012.10.011. Epub 2013 Apr 30. Rev Port Cardiol. 2013. PMID: 23639325 English, Portuguese.
-
Percutaneous occlusion of the left atrial appendage for systemic embolism prevention in patients with atrial fibrillation: state of the art and report of two cases.Ital Heart J. 2005 May;6(5):409-13. Ital Heart J. 2005. PMID: 15934415
-
Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.Rev Neurol (Paris). 2015 May;171(5):426-32. doi: 10.1016/j.neurol.2014.11.009. Epub 2015 Apr 23. Rev Neurol (Paris). 2015. PMID: 25912470 Review.
-
The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):100-3. doi: 10.14797/mdcj-11-2-100. Methodist Debakey Cardiovasc J. 2015. PMID: 26306127 Free PMC article. Review.
Cited by
-
Stroke prevention in atrial fibrillation: warfarin faces its challengers.Curr Cardiol Rep. 2005 Jan;7(1):16-22. doi: 10.1007/s11886-005-0005-7. Curr Cardiol Rep. 2005. PMID: 15610642 Review.
-
Haemodynamic and functional consequences of the iatrogenic atrial septal defect following Mitraclip therapy.Neth Heart J. 2017 Feb;25(2):137-142. doi: 10.1007/s12471-016-0928-1. Neth Heart J. 2017. PMID: 27896596 Free PMC article. Review.
-
Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: a pilot study.J Cardiovasc Magn Reson. 2011 Jul 4;13(1):33. doi: 10.1186/1532-429X-13-33. J Cardiovasc Magn Reson. 2011. PMID: 21726450 Free PMC article.
-
Post mortem analysis of a left atrial appendage occlusion device (PLAATO) in a patient with permanent atrial fibrillation.J Interv Card Electrophysiol. 2005 Oct;14(1):17-20. doi: 10.1007/s10840-005-3489-6. J Interv Card Electrophysiol. 2005. PMID: 16311934
-
Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility.Med Devices (Auckl). 2016 Sep 2;9:309-16. doi: 10.2147/MDER.S65492. eCollection 2016. Med Devices (Auckl). 2016. PMID: 27621674 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical